TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Invion ( (AU:IVX) ) has issued an update.
Invion Limited has announced a change in the interests of its director, Chiat Thian Chew, involving the lapse and cancellation of 1,384,886 unlisted options without conversion. This adjustment in the director’s securities holdings reflects a strategic decision that may impact the company’s governance and shareholder dynamics.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on the development of treatments for chronic inflammatory diseases. The company is involved in the research and commercialization of pharmaceutical products.
Average Trading Volume: 120,749
Technical Sentiment Signal: Sell
Current Market Cap: A$10.28M
For an in-depth examination of IVX stock, go to TipRanks’ Overview page.